Autologous Peripheral Blood Hematopoietic Cell Transplantation in Dogs with B-cell Lymphoma

Journal of Veterinary Internal Medicine

Volumn 26, Issue 5, 2012, Pages 1155-1163

  Willcox, J L ^a   Pruitt, A ^a   Suter, S E ^b  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

Cancer; Canine B cell lymphoma; CD34+ transplantation

Indexed keywords

ANIMAL; ANIMAL DISEASE; ARTICLE; B CELL LYMPHOMA; CELL SEPARATION; DISEASE FREE SURVIVAL; DOG; DOG DISEASE; FEMALE; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; KAPLAN MEIER METHOD; MALE; METHODOLOGY; PATHOLOGY; STANDARD; WHOLE BODY RADIATION;

ANIMALS; CELL SEPARATION; DISEASE-FREE SURVIVAL; DOG DISEASES; DOGS; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; KAPLAN-MEIER ESTIMATE; LYMPHOMA, B-CELL; MALE; WHOLE-BODY IRRADIATION;

ANIMALIA; CANIS FAMILIARIS;

EID: 84866308864     PISSN: 08916640     EISSN: 19391676     Source Type: Journal    
DOI: 10.1111/j.1939-1676.2012.00980.x     Document Type: Article

References (35)

1. Kaiser HE. Animal neoplasms: A systemic review. In: Kaiser HE, ed. Neoplasms: Comparative Pathology in Animals, Plants, and Man. Baltimore, MD: William & Wilkins; 1981:747-812.
2. Moulton JE, Harvey JW. Tumors of lymphoid and hematopoietic tissue. In: Moulton JE, ed. Tumors of Domestic Animals, 3rd ed. Berkeley, CA: University of California Press; 1990:119-144.
3. Garrett LD, Thamm DH, Chun R, et al. Evaluation of a 6-month chemotherapy protocol with no maintenance therapy for dogs with lymphoma. J Vet Intern Med 2002;16:704-709.
4. Moore AS, Cotter SM, Rand WM, et al. Evaluation of a discontinuous treatment protocol (VELCAP-S) for canine lymphoma. J Vet Intern Med 2001;15:348-354.
5. Williams LE, Johnson JL, Hauck ML, et al. Chemotherapy followed by half-body radiation therapy for canine lymphoma. J Vet Intern Med 2004;18:703-709.
6. Keller ET, MacEwen EG, Rosenthal RG. Evaluation of prognostic factors and sequential combinaton chemotherapy with doxorubicin for canine lymphoma. J Vet Intern Med 1993;7:289-295.
7. Myers NC 3rd, Moore AS, Rand WM, et al. Evaluation of a multidrug chemotherapy protocol (ACOPA II) in dogs with lymphoma. J Vet Intern Med 1997;11:333-339.
8. Goodman G, Hodges GS. Evidence for stem cells in the peripheral blood of mice. Blood 1962;19:702-704.
9. Storb R, Graham TC, Epstein RB, et al. Demonstration of hemopoietic stem cells in the peripheral blood of baboons by cross circulation. Blood 1977;50:537-542.
10. de Revel T, Appelbaum FR, Storb R, et al. Effects of granulocyte colony-stimulating factor and stem cell factor, alone and in combination, on the mobilization of peripheral blood cells that engraft lethally irradiated dogs. Blood 1994;83:3795-3799.
11. Lupu M, Storb R. Five decades of progress in haematopoietic cell transplantation based on the preclinical canine model. Vet Comp Oncol 2007;5:14-30.
12. Suter SE. Collection of peripheral blood CD34+ progenitor cells from healthy dogs and dogs diagnosed with lymphoproliferative diseases using a Baxter-Fenwal CS-3000 Plus blood cell separator. J Vet Intern Med 2011;25:1406-1413.
13. Siena S, Bregni M, Brando B, et al. Flow cytometry to estimate circulating hematopoietic progenitors for autologous transplantation: Comparative analysis of different CD34 monoclonal antibodies. Haematologica 1991;76:330-333.
14. Bensinger W, Singer J, Appelbaum F, et al. Autologous transplantation with peripheral blood mononuclear cells collected after administration of recombinant granulocyte stimulating factor. Blood 1993;81:3158-3163.
15. Appelbaum FR, Deeg HJ, Storb R, et al. Cure of malignant lymphoma in dogs with peripheral blood stem cell transplantation. Transplantation 1986;42:19-22.
16. Philip T. High dose therapy and ABMT rescue in lymphoma and solid tumours. Eur J Cancer 1995;31A:808-809.
17. Lurie DM, Gordon IK, Theon AP, et al. Sequential low-dose rate half-body irradiation and chemotherapy for the treatment of canine multicentric lymphoma. J Vet Intern Med 2009;23:1064-1070.
18. Frimberger AE, Moore AS, Rassnick KM, et al. A combination chemotherapy protocol with dose intensification and autologous bone marrow transplant (VELCAP-HDC) for canine lymphoma. J Vet Intern Med 2006;20:355-364.
19. Lupu M, Sullivan EW, Westfall TE, et al. Use of a multigeneration-family molecular dog leukocyte antigen typing to select a hematopoietic cell transplant donor for a dog with T-cell lymphoma. J Am Vet Med Assoc 2006;228:728-732.
20. Chan G, Nelson M, Hawkins J, et al. An efficient and cost effective method of maximizing peripheral blood progenitor collection in children. J Clin Apher 1999;14:82-85.
21. Lupu M, Gooley T, Zellmer E, et al. Principles of peripheral blood mononuclear cell apheresis in a preclinical canine model of hematopoietic cell transplantation. J Vet Intern Med 2008;22:74-82.
22. Gidron A, Verma A, Doyle M, et al. Can the stem cell mobilization technique influence CD34+ cell collection efficiency of leukapheresis procedures in patients with hematologic malignancies? Bone Marrow Transplant 2005;35:243-246.
23. Burnett RC, Vernau W, Modiano JF, et al. Diagnosis of canine lymphoid neoplasia using clonal rearrangements of antigen receptor genes. Vet Pathol 2003;40:32-41.
24. Bean MA, Storb R, Graham T, et al. Prevention of transfusion-induced sensitization to minor histocompatibility antigens on DLA-identical canine marrow grafts by gamma irradiation of marrow donor blood. Transplantation 1991;52:956-960.
25. VCOG. Veterinary cooperative oncology group-common terminology criteria for adverse events (VCOG-CTCAE) following chemotherapy of biological antineoplastic therapy in dogs and cats v1.1. Vet Comp Oncol 2011;DOI:10.1111/j.1476-5829.
26. Escobar C, Grindem C, Neel JA, et al. Hematologic changes after total body irradiation and autologous transplantation of hematopoietic peripheral blood progenitor cells in dogs with lymphoma. Vet Pathol 2012;49:341-343.
27. Deeg HJ. Acute and delayed toxicities of total body irradiation. Seattle Marrow Transplant Team. Int J Radiat Oncol Biol Phys 1983;9:1933-1939.
28. Deeg HJ, Prentice R, Fritz TE, et al. Increased incidence of malignant tumors in dogs after total body irradiation and marrow transplantation. Int J Radiat Oncol Biol Phys 1983;9:1505-1511.
29. Blystad AK, Delabie J, Kvaloy S, et al. Infused CD34 cell dose, but not tumour cell content of peripheral blood progenitor cell grafts, predicts clinical outcome in patients with diffuse large B-cell lymphoma and follicular lymphoma grade 3 treated with high-dose therapy. Br J Haematol 2004;125:605-612.
30. Yoon DH, Sohn BS, Jang G, et al. Higher infused CD34+ hematopoietic stem cell dose correlates with earlier lymphocyte recovery and better clinical outcome after autologous stem cell transplantation in non-Hodgkin's lymphoma. Transfusion 2009;49:1890-1900.
31. Shpall EJ, Champlin R, Glaspy JA. Effect of CD34+ peripheral blood progenitor cell dose on hematopoietic recovery. Biol Blood Marrow Transplant 1998;4:84-92.
32. Kopp HG, Yildirim S, Weisel KC, et al. Contamination of autologous peripheral blood progenitor cell grafts predicts overall survival after high-dose chemotherapy in multiple myeloma. J Cancer Res Clin Oncol 2009;135:637-642.
33. DiPersio JF, Ho AD, Hanrahan J, et al. Relevance and clinical implications of tumor cell mobilization in the autologous transplant setting. Biol Blood Marrow Transplant 2011;17:943-955.
34. Weekes CD, Pirruccello SJ, Vose JM, et al. Lymphoma cells associated with bone marrow stromal cells in culture exhibit altered growth and survival. Leuk Lymphoma 1998;31:151-165.
35. Sharp JG, Chan WC. Detection and relevance of minimal disease in lymphomas. Cancer Metastasis Rev 1999;18:127-142.